Additional and CDK‐independent oncogenic functions of p27 have been proposed and were substantiated in a knock‐in mouse with a mutant p27 that is unable to bind cyclin/CDK complexes (p27CK−) and thereby loses its function as a tumour suppressor. The gene discussed is CDKN1B; the disease is neoplasm.